Clinical Trials Logo

Clinical Trial Summary

The prevalence of opioid use disorder (OUD) and opioid-related deaths has risen dramatically in recent years. Effective treatments, including medications for opioid use disorder (MOUDs; e.g., buprenorphine-naloxone and methadone) are under-utilized. There are few evidence-based interventions for changing attitudes toward Opioid Use Disorder (OUD) in the general public and especially among healthcare clinicians. This study proposes an innovative intervention to change attitudes of Primary Care Clinicians (PCCs) toward persons with OUD. Study participants will be stratified into one of two online learning courses: the intervention training will be compared with an attention-control training.


Clinical Trial Description

Primary care offers an ideal setting in which to treat OUD; however, few clinicians are waivered to prescribe buprenorphine and of those who are waivered, less than one-third do prescribe. One potential barrier to increasing access to MOUDs are primary care clinician (PCC) attitudes towards people with OUD. This study will use a randomized controlled trial design to examine a novel intervention to change attitudes towards people with OUD among PCCs. PCCs in clinics randomized in COMPUTE 2.0 to the intervention (in 15 of the 30 clinics randomized in the parent study) will be randomized 1:1 to the intervention or comparison training, stratified by clinic and waiver status. Training will be conducted via MyLearning, an online learning software. PCCs will be asked to complete a brief training on the clinical decision support (CDS) tool, Opioid Wizard. PCCs in the intervention arm will hear patient narratives designed to shift attitudes about patients with OUD. PCCs in the comparison training will have training on using the clinical decision support tool. Immediately following the training, the PCCs will complete a survey of attitudes and intentions to get waivered to prescribe buprenorphine. Use of the CDS will be monitored in both groups for 6 months. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04867382
Study type Interventional
Source HealthPartners Institute
Contact Amy B LaFrance, MPH
Phone 9529675079
Email [email protected]
Status Recruiting
Phase N/A
Start date March 9, 2021
Completion date November 11, 2021

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04527926 - STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy N/A
Recruiting NCT04505540 - Start Treatment and Recovery for Opioid Use Disorder N/A
Recruiting NCT03065049 - Transforming Recovery Through Exercise and Community N/A
Completed NCT04080037 - Assessing Opioid Care Practices Using CPV Patient Simulation Modules N/A
Recruiting NCT04650386 - Examining an Adaptive Approach to Providing Psychosocial Support to Buprenorphine Patients N/A
Not yet recruiting NCT04479475 - Social Networks and Methadone Maintenance Treatment Retention and Antiretroviral Therapy Retention in Tanzania N/A
Not yet recruiting NCT04783558 - Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk Pregnant Women N/A
Completed NCT03715634 - Study of a Novel Subcutaneous Depot Formulation of Buprenorphine Phase 1
Active, not recruiting NCT04122755 - Single Ascending Dose Study of ALA-1000 Phase 1
Recruiting NCT04129580 - reSET-O RCT (Randomized Controlled Trial) N/A
Recruiting NCT03923374 - Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes
Not yet recruiting NCT04480554 - Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1 Phase 2
Recruiting NCT02687360 - Imaging the Effects of rTMS on Chronic Pain N/A
Completed NCT04056182 - Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment Phase 2
Completed NCT03766893 - Medication Maintenance Therapy in Community Pharmacy Settings Early Phase 1
Completed NCT03279562 - Patient Driven Recovery With Nalmefene and Coaching Phase 1
Recruiting NCT04248933 - Peer-Delivered Behavioral Activation for Methadone Adherence - Pilot Phase N/A
Not yet recruiting NCT03266445 - Effect of Buprenorphine/Naloxone Continuation on Pain Control and Opioid Use Phase 4
Completed NCT03851731 - Evaluation of Intranasal Naltrexone and Naloxone Phase 1
Recruiting NCT03933865 - Acute Pain Management in Patients on Opioid Replacement Therapy Phase 1